Study to Evaluate Efficacy, Safety and Tolerability of PENNEL Capsule in the Patients With Chronic Liver Disease

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 1996

Primary Completion Date

May 31, 1997

Study Completion Date

October 31, 1997

Conditions

Chronic Liver Disease

Interventions

DRUG

PENNEL capsule

"hard capsule DDB 25mg \& GO 50mg in cap .......... 1 capsule~1 or 2 capsule, T.I.D"

DRUG

Placebo

Trial Locations (2)

Hanyang University Hospital, Seoul

Korea Cancer Center Hospital, Seoul